Top stocks in focus today: Fortis Healthcare, Coal India, Aurobindo, Hero MotoCorp
These companies will be in focus during trade today based on recent and latest news developments.
Manipal Health Enterprises is set to acquire Fortis Healthcare for Rs6,500cr, according to the media news. The deal is likely to be formalized this week. The Abu Dhabi-based VPS Healthcare and IHH of Malaysia are also interested in the troubled healthcare chain.
Coal India achieved 89% of the targeted coal production at 54.46 million tonnes in February 2018. Actual offtake was 96% of the targeted at 49.97 million tonnes in February 2018.
Hero MotoCorp February sales up 20% year-on-year to 6,29,597 units.
USFDA has issued nine observations at Aurobindo’s injectable manufacturing unit IV. This unit underwent USFDA inspection between February 12 to February 18, 2018.
TVS Srichakra said it is acquiring 5 lakh equity shares in ZF Electronics (TVS) India through its wholly owned subsidiary, TVS Srichakra Investments.
NMDC has commissioned 220KV GIS (Gas Insulated Switch) at its upcoming steel plant at Nagarnar, Chhattisgarh.
Dilip Buildcon has received Letter of Awards by the National Highways Authority of India for two new Hybrid Annuity Projects valued at Rs4,473cr in the State of Karnataka.
The extraordinary general meeting of shareholders of Canara Bank has approved through a special resolution to allot 13,59,54,616 equity shares of Rs10 each for cash at an issue price of Rs357.84 for an aggregate amount of Rs4,865cr on preferential basis to the government of India.
Reliance Infra board meeting on March 7 to raise funds through QIP.
BEL buyback period between March 5-16.
Balrampur Chini ex-date for determining buyback eligibility.
TVS Motor February sales up 37% year-on-year to 2,90,673 units.
Wipro to acquire 33.33% stake in the U.S. based application security solution provider, Denim group for $8.8mn.
Punjab National Bank raised interest rates by 10-45 basis points on various tenures.
JBM Auto board approved the scheme of amalgamation of JBM Auto Systems and JBM MA Automotive with self.
Laurus Labs said that the U.S.FDA completed the inspection of its Unit 2 with zero observations under Form 483, and received maiden approval from the drug regulator for TDF tablets used in the treatment of HIV-1 infection.
L&T Finance to consider issue price for preferential issue to L&T on March 7.
HealthCare Global Enterprises entered into an agreement with promoter to buy a cancer care hospital for Rs52cr.